Darunavir is a second-generation HIV protease inhibitor designed to maintain activity against many resistant viral strains. It is a sulfonamide compound with a complex polycyclic structure, used in pharmaceutical manufacturing as an active pharmaceutical ingredient.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 206361-99-1
Darunavir ethanolate
pharmaceutical raw material
Darunavir propylene glycolate
pharmaceutical intermediate
Carbamic acid, N-[(1S,2R)-3-[[[4-(acetylamino)phenyl]sulfonyl](2-methylpropyl)amino]-2-hydroxy-1-(phenylmethyl)propyl]-, (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl ester
pharmaceutical raw material
N-{4-[{(2R,3S)-3-[({[(3R,3aS,6aR)-Hexahydrofuro[2,3-b]furan-3-yl]oxy}carbonyl)amino]-2-hydroxy-4-phenylbutyl}(2-methylpropyl)sulfamoyl]phenyl}-beta-D-glucopyranuronosylamine
pharmaceutical raw material
Vincristine sulfate
pharmaceutical raw material
Bamifylline hydrochloride
pharmaceutical raw material
Nefextinib
pharmaceutical raw material
Methyl (S)-phenyl[(R)-piperidin-2-yl]acetate
pharmaceutical raw material
[(3aS,4R,6aR)-2,3,3a,4,5,6a-hexahydrofuro[2,3-b]furan-4-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamate
CJBJHOAVZSMMDJ-HEXNFIEUSA-N
CC(C)CN(C[C@H]([C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CO[C@@H]3[C@H]2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N